Calidi Biotherapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -426 | -423 | -427 | -407 |
EBITDA | -3,761 | -3,596 | -4,703 | -5,298 |
EBIT | -4,187 | -4,019 | -5,130 | -5,705 |
Net Income | -4,108 | -4,056 | -5,149 | -5,715 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,121 | -5,073 | -4,265 | -4,937 |
Cash | 6,631 | 5,600 | 10,375 | 5,279 |
Basic Shares | 10,308 | 7,216 | 4,907 | 2,877 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $45 |
Gross Profit | -1,651 | -1,535 | -1,256 | -229 |
EBITDA | -18,589 | -19,727 | -24,195 | -24,998 |
EBIT | -20,240 | -21,262 | -25,451 | -25,258 |
Net Income | -19,906 | -22,143 | -29,216 | -25,427 |
Net Change In Cash | 0 | 0 | 0 | 45 |
Free Cash Flow | -21,413 | -19,710 | -27,568 | -13,642 |
Cash | 5,600 | 9,591 | 2,049 | 372 |
Basic Shares | 4,302 | 664 | 140 | 70 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$2.21 |
2025-06-30 | -$1.99 |
2025-03-31 | -$0.18 |
2024-12-31 | -$0.27 |